Multi-Modal MRI Assessments of Kidney Disease Severity in Autosomal Recessive Polycystic Kidney Disease

2024-9-1

Opportunities in primary and enteric hyperoxaluria at the cross-roads between the clinic and laboratory

2024-9-1

Perspectives of caregivers on access to healthcare for children with chronic kidney disease

2024-9-1

Exploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases

2024-9-1

Perspectives of patients and clinicians on reproductive healthcare and autosomal dominant polycystic kidney disease

2024-9-1

Scoping review of economic analyses of rare kidney diseases

2024-9-1

Steroid-Resistant Nephrotic Syndrome is Associated with a Unique Genetic Profile in a Highly Admixed Pediatric Population

2024-9-1

Combination therapy with rituximab and low dose cyclophosphamide and prednisone in membranous nephropathy

2024-9-1

Kidney Beam - a cost-effective digital intervention to improve mental health.

2024-9-1

Clinical practice recommendations on kidney management in methylmalonic acidemia: an expert consensus statement from ERKNet and MetabERN

2024-9-1

Response to: “Implications of the choice of different calculation concepts for eGFRcys-to-eGFRcre ratio among community-dwelling older adults”

2024-9-1

Nephrologists’ views on a workflow for returning genetic results to research participants.

2024-9-1

Implications of the choice of different calculation concepts for eGFRcys-to-eGFRcre ratio among community-dwelling older adults

2024-9-1

Age-related differences in rejection rates, infections and tacrolimus exposure in pediatric kidney transplant recipients in the CERTAIN registry

2024-9-1

Review of Exercise Interventions to Improve Clinical Outcomes in Non-dialysis Chronic Kidney Disease

2024-8-1

Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination–Associated Thrombotic Microangiopathy

2024-8-1

Urinary soluble CD163: A novel biomarker suggests who should receive glucocorticoids in IgA nephropathy

2024-8-1

IMPACT CKD: Holistic disease model projecting 10-year population burdens

2024-8-1

Bridging the Gap in Genomic Implementation: Identifying User Needs for Precision Nephrology

2024-8-1

Implementation and Evaluation of a National Multidisciplinary Kidney Genetics Clinic Network Over 10 Years

2024-8-1

Cardioprotective effect of SGLT2 inhibitor in diabetic kidney transplant recipients: A multicenter propensity score matched study

2024-8-1

Clinicopathologic Features of IgG4-Related Kidney Disease

2024-8-1

Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions

2024-8-1

Economic evaluation of an integrated care program compared to conventional care for chronic kidney disease patients in rural communities of Thailand

2024-8-1

Rethinking Living Donor Kidney Transplantation Through a Healthcare System Lens

2024-8-1

Donor Perceptions and Preferences of Telemedicine and In-Person Visits for Living Kidney Donor Evaluation

2024-8-1

Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older Adults

2024-8-1

Comprehensive conservative care for kidney failure - The need for evidence-based guidance

2024-8-1

Response to Comment on “Effect of Belimumab on Preventing de novo Renal Lupus Flares”

2024-8-1

Q Fever-Related Glomerulonephritis unveiled by Metagenomic Next-Generation Sequencing

2024-8-1

Comment on “Belimumab on Preventing de novo Renal Flares”

2024-8-1

Role of bile acid receptors in the development and function of diabetic nephropathy

2024-8-1

Open-label phase I/II study of Daratumumab-based desensitization before kidney transplantation

2024-8-1

Fracture risk in hemodialysis patients: the lower the PTH the better?

2024-8-1

Cost-utility of real-time potassium monitoring in United-States patients receiving hemodialysis

2024-8-1

Extremely Long-lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-based Regimen in Lupus Nephritis

2024-8-1

Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians

2024-8-1

Correlation of urinary soluble CD163 levels with disease activity and treatment response in IgA nephropathy

2024-8-1

Corrigendum to “WCN24-1066 BRIDGING THE GAP: INTEGRATING THE MULTIDISCIPLINARY EQUIPMENT ON HEMODIALYSIS VASCULAR ACCESS FROM LATIN AMERICA AND PERÚ” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S379-S380]

2024-8-1

Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial

2024-8-1

Acute Kidney Injury and Hair-Straightening Products

2024-8-1

Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study

2024-8-1

Obinutuzumab as Initial or Second-line Therapy in Patients With Primary Membranous Nephropathy

2024-8-1

Urinary sC5b-9 is better linked to albuminuria than to intra-renal inflammation in common kidney disease.

2024-8-1

TRPC6-Calpain1 Axis Promotes Tubulointerstitial Inflammation by Inhibiting Mitophagy in Diabetic Kidney Disease

2024-8-1

Paradigm Shift: Dialysis as a Terminal Condition

2024-8-1

The Role of Urate in Calcium Stone Formation

2024-8-1

Response to “Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients”

2024-8-1

Randomized Trial Patiromer on Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients Treated with Hemodialysis

2024-8-1

Adverse events associated with SARS-CoV-2 vaccination in patients with glomerular diseases and the potential risk of disease reactivation

2024-8-1